Docoh
Loading...

NRIX Nurix Therapeutics

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On May 6, 2021, Nurix Therapeutics, Inc. (the “Company”) held its virtual 2021 Annual Meeting of Stockholders exclusively online via live webcast (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 25, 2021. There were 34,460,833 shares of common stock present at the Annual Meeting in person or by proxy, which represented approximately 77.76% of the voting power of the shares of common stock entitled to vote at the Annual Meeting and constituted a quorum for the transaction of business. Holders of the Company’s common stock were entitled to one vote for each share held as of the close of business on March 12, 2021.

The stockholders of the Company voted on the following proposals at the Annual Meeting:

1. To elect two Class I directors, each of whom is currently serving on the Company’s Board of Directors, each to serve a three-year term expiring at the Company’s 2024 annual meeting of stockholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, disqualification or removal.

2. To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2021.

The final voting results for each of these proposals are detailed below.

Proposal 1. Election of Directors

NomineeVotes ForVotes WithheldBroker Non-Votes
David Lacey, M.D.30,425,2901,965,5112,070,032
Julia P. Gregory26,971,6385,419,1632,070,032


Each of the two nominees for director was elected to serve until the Company’s 2024 annual meeting of stockholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, disqualification or removal.

Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm

Votes ForVotes AgainstAbstentionsBroker Non-Votes
34,381,97677,979878


The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2021.

2